Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 648

PDF Downloaded: 444


Get Permission Gavaniya, Thaker, Radadiya, Patel, Barot, and Desai: Complications of placenta previa: A retrospective observational study at tertiary care hospital


Introduction

Placenta previa (PP) is condition where the placenta is inserted completely or partially into the lower uterine segment, at or after 28 weeks of gestation.1 It complicates 0.3-0.5% of all pregnancies at term.2 Its incidence is increased due to various reasons including wide spread use of ultrasound scanning and increasing rates of caesarean deliveries. It is fatal in 0.03% of patients. Regardless of etiology, maternal and fetal risks are increased by several folds in patient of placenta previa; in mother, the risks are mainly due to life threatening APH and postpartum haemorrhage (PPH). Placenta previa is a major cause of antepartum haemorrhage (APH) accounting for 35% of all the causes.3 Chances of abnormal adherence of placenta is also increased several times. With regard to baby, incidences of low birth weight (LBW), intra uterine growth restriction (IUGR), preterm deliveries and congenital malformations are increased. Once diagnosed, placenta previa and morbidly adherent placenta should be managed at tertiary care centre with multidisciplinary approach so as to lessen the maternal and fetal morbidity and mortality. The purpose of this study was to determine the proportion of placenta previa, the demographics of patients, types and severity, complications and the feto-maternal outcome in patients of placenta previa.

Materials and Methods

After due permission of Institutional Review Board (NHLIRB/2023/March/32/No.11), this retrospective observational study was carried out at our tertiary care teaching hospital from July 2020 to November 2022. The data was collected after approval of Institutional Review Board. Data was collected from the indoor case papers and hospital records as per proforma that included, demographic profile of patients, detailed history, clinical examination findings, investigations, gestational age at the time of delivery, progress of labour, mode of delivery, feto-maternal outcome and complications. Analysis of data was done by appropriate statistical methods.

Patients diagnosed with placenta previa, irrespective of their parity and fetal viability were included.

Inclusion criteria

  1. Symptomatic / Asymptomatic patients with clinical and radiological diagnosis of placenta previa including patients of placenta accreta, increta or percreta

  2. Undiagnosed placenta previa confirmed intra-operatively during CS.

    1. Type I: Minor Previa: lower placental edge inside the lower uterine segment, not up to internal os.

    2. Type II: Marginal Previa: lower placental edge just reaching the internal os.

    3. Type III: Partial Previa: partially covering the internal os when closed but does not entirely do so when fully dilated.

    4. Type IV: Complete Previa: Placenta completely covering the internal os.

  3. For clinical purpose, the types were graded into mild degree (Type I and Type II A anterior) and major degree (Type II B posterior, Type III and Type IV).

New classification based on ultrasound finding;

Placenta Previa; the internal os is covered partially or completely by placenta.

Low lying placenta; implantation in the lower uterine segment is such that the placental edge does not cover the internal os but lies within a 2-cm wide perimeter around the os.

Exclusion criteria

  1. All patients of Placenta Previa, whose follow- up was lost.

  2. Patient suffering from bleeding disorder.

Results

During the study period, 13,354 patients were admitted for management of pregnancy at our tertiary care teaching hospital. Out of these patients diagnosed with placenta previa were 48. Hence, the proportion of pregnancies with placenta previa was 0.3%.

Table 1

Demographic details and obstetric profile

Demographic Details and Obstetric Profile

Degree of Placenta Previa

Total No. (%) N = 48

Minor (low lying placenta) No. (%) N = 7

Major (placenta previa) No. (%) N = 41

Type of Admission

Registered

06 (12.5%)

38 (79.2%)

44 (91.7%)

Unregistered

01 (2.1%)

03 (6.2%)

04 (8.3%)

Age Group

21-25 years

02 (4.2%)

11(22.9%)

13 (27.1%)

26-30 years

04 (8.3%)

21 (43.8%)

25 (52.1%)

31-35 years

01 (2.1%)

06 (12.5%)

07 (14.6%)

36-40 years

0

03 (6.2%)

03 (6.2%)

Gravida

Primigravida

03 (6.2%)

07(14.6%)

10(20.8%)

Multigravida

04 (8.3%)

34 (70.8%)

38 (79.1%)

Period of Gestation

28 to 33 weeks

02 (4.2%)

05 (10.4%)

07 (14.6%)

34 to 36 weeks

01(2.1%)

11 (22.9%)

12 (25.0%)

> 37 weeks

04 (8.3%)

25(52.1%)

29(60.4%)

As shown in Table 1, majority 44(91.7%) patients were registered patients. Majority 38(79.2%) of patients were from the peak reproductive age group of 21 to 30 years. Proportion of placenta previa was almost double in age group of 26-30 years compared to 21-25 years. Majority 38(79.1%) patients were multigravida. Majority of patients 41 (85.4%) had major degree of placenta previa in which Type II B(posterior) in 14(29.2%) patients, Type III in 8 (16.6%) and Type IV in 19 (39.6%)and 7 (14.6%) had minor degree of placenta previa in which Type I in 6 (12.5%) patients and Type IIA (anterior) in 1 (2.1%) patients. Majority 29(60.4%) patients admitted with full term after 37 weeks of gestation.

Table 2

Mode of delivery

Mode of Delivery

No.

Percentage (%)

Caesarean Section

Emergency

41

85.4%

Elective

6

12.5%

Vaginal Delivery

1

2.1%

Total

48

100%

As shown in Table 2, caesarean section remains choice of delivery, majority 47(97.9%) of patients were delivered by caesarean section; of these elective and emergency caesarean sections were 41 (85.4%) and 6 (12.5%) respectively. Normal vaginal delivery occurred in 1(2.1%) patient having minor degree of placenta previa who came in labour.

Table 3

Complications and relation to degree of placenta previa

Complications and Relation to Degree of Placenta Previa

Minor (N=7)

Major (N=41)

Total (N=48)

Percentage (%)

Antepartum

Number of Episodes of Bleeding/APH

0

3(6.2%)

22(45.8%)

25

52%

1

4(8.3%)

15(31.3%)

19

47.9%

2

0(0.0%)

02(4.2%)

02

>2

0(0.0%)

02(4.2%)

02

Intra Operative

Placenta

Accreta Syndrome

Placenta Accreta

0

1

2

4.2%

(Adherent Placenta)

Placenta Increta

0

1

Urinary Bladder Injury

0

2

2

4.2%

Post-Partum

PPH

2

20

22

45.8%

Management of PPH (more than one modality in some patients)

Medical Management

22

45.8%

Medical Management plus

Bilateral uterine artery ligation (BLUAL)

19

39.8%

BLUAL + Uterine packing

2

4.2%

Uterine packing

1

2.1%

B-Lynch suture

1

2.1%

Obstetric hysterectomy

6

12.5%

Blood and Blood Components

22

45.8%

DIC

0

2

2

4.2%

Renal Failure

1

0

1

2.1%

Fever

1

1

2

4.2%

Wound Gap

1

0

1

2.1%

Maternal Death

0

1

1

2.1%

As shown in Table 3, 23 (47.9%) of patients had bleeding episodes/APH in antenatal period and PPH were reported in 22 (45.8%) patients. Placenta was adherent in 2 (4.2%) patients of placenta previa. Medical management was done in form of uterotonics and pressure was applied for hemostasis in all patients. Complete hemostasis was achieved by medical management and/or surgical management. Bilateral uterine artery ligation (BLUAL) was performed in 19(39.6%) and uterine packing was done in 2(4.2%). BLUAL along with uterine packing and B-Lynch suture was required in 1(2.1%) each. Obstetric hysterectomy was required in 4(8.3%) patients when all other modalities for management of PPH failed and in 2(4.2%) patients of adherent placenta.

Maternal mortality occurred in 1(2.1%) patient due to PPH and patient could not be saved despite obstetric hysterectomy. Placenta was adherent and on HPE, it was diagnosed as placenta increta. This patient had previous history of D/E and history of previous CS done for placenta previa. In all patients of PPH, hypovolemia was corrected by crystalloid and blood transfusion. In present study, all 22(45.8%) patients required transfusion of blood and blood components.

Table 4

Maternal hemoglobin and blood transfusion

Baseline Maternal Hb (gm%) On Admission

No. of units of blood Transfused

Blood transfusion required

Number of Patients

Blood transfusion not required Number of patients

Total no. of Patients (%)

1 Unit

2 Unit

3 Unit

4 Unit

>4 Unit

<7

0

0

0

0

0

0

0

0

7-8.9

0

3

1

1

0

5

0

5(10.4%)

9-10.9

7

4

1

2

2

16

4

20(41.7%)

>11

6

3

0

1

1

11

12

23(47.9%)

As shown in Table 4, requirement of blood transfusion depended on baseline hemoglobin level and amount of blood loss. More than 4 units of blood was required in 3(6.3%) patients whose baseline Hb was >9gm/dl, but they had developed PPH. In this present study, no patient was severely anemic. Majority of patients, 20 (41.7%) had mild anemia.

Table 5

Perinatal outcome in patients of placenta previa (N=48)

Perinatal Outcome

Number

Percentage (%)

Alive

44

91.7%

IUD

0

0.0%

Still Birth

0

0.0%

Neonatal Death

4

8.3%

Total

48

100%

As shown in Table 5, all babies were live at time of birth and 44(91.7%) babies were alive at the time of discharge and neonatal death occurred in 4 (8.3%).

Table 6

Relationship of gestational age, baby weight and perinatal outcome

Birth Weight

Gestational Age and Perinatal Outcome

Total Number (%)

Alive

IUD/Still Birth

Neonatal Death

28-33

34-36

>37

28-33

34-36

>37

28-33

34-36

>37

<1 kg

0

0

0

0

0

0

1

0

0

1(2.1%)

1-1.5 kg

0

0

0

0

0

0

2

0

0

2(4.2%)

1.6-2 kg

2

2

0

0

0

0

1

0

0

5(10.4%)

2.1-2.5 kg

1

7

11

0

0

0

0

0

0

19(39.6%)

>2.5 kg

0

3

18

0

0

0

0

0

0

21(43.7%)

Total

3

12

29

0

0

0

4

0

0

48(100%)

As shown in Table 6, of 44 babies who survived, 4 babies weighted below 2kg and 40 babies weighed >2kg. Majority 29(60.4%) babies delivered at full term while 19(39.6%) babies reported preterm In present study, there was no IUFD. Neonatal mortality occurred in 4(8.3%) preterm babies (28-33 week gestation), of these 2 babies weighed 1.3 kg, 1.4 kg (between 1- 1.5kg).

Discussion

In present study, proportion of placenta previa was 0.3%. Studies done by Bahar A et al,4 Rosenberg T et al,5 Rahim N et al,6 Meena N et al,7 Naik VR et al,8 Ramasamy P et al9 have reported proportion of placenta previa as 0.7%, 0.4%, 0.7%, 0.8%, 1.4%, 0.6% respectively. The incidence of placenta previa has risen in past 30 years. As per Parkland hospital statistics it has risen from 2.6 per 1000 to 3.8 per 1000.10

In our study, majority, 44 (91.7%) patients were registered and 4 (8.3%) were unregistered patients. Mathuriya G. et al11 and Rahim N et al6 have reported majority of unregistered patients, that were 96.4% and 65.5% respectively. In present study, majority of patients were registered. This finding suggests that, there is increased awareness regarding early registration and need for antenatal care at tertiary care hospital due to availability of multi-disciplinary care.

In present study, majority of patients were 38 (79.2%) were in age group of 21-30 years. This is because of the peak reproductive age group, early age of marriage and shorter interval between the pregnancies. Banu N et al,12 Purohit A et al,13 Meena et al,7 Naik VR et al,8 Maiti GD et al14 and Ramasamy P et al9 have also reported majority of patients having placenta previa in age group of 21-30 years as 85.7%, 75.5%, 70.4%, 49.0%, 50.0%, 76.0% respectively.

In present study, 10 (20.8%) patients were primigravida and 38 (79.1%) patients were multigravida. Multiparous patients have shown the higher incidence of placenta previa. This is associated with the ageing of vasculature of the uterus. This causes placental hypertrophy and enlargement which increases the likelihood of the placenta encroaching on lower uterine segment. Advanced maternal age and parity are confounding.10 Studies by Lele S. B et al,15 Das B. et al,16 Tuzovic L et al.,17 Jilliani K et al,18 Ojha N. et al,19 Naik VR et al,8 Maiti GD et al,14 Ramasamy P et al9 have also reported majority of patients having placenta previa were multigravida in 88.95%, 87.8%, 71.6%, 86.2%, 61.4%, 79.2%, 76.7% and 74.0% respectively.

In present study, majority 29 (60.4%) patients were admitted after 37 weeks. But we can diagnose placenta previa and low lying placenta with the help of ultrasound at 32 week. 10Ojha N. et al,19 Berhan Y. et al,20 Maiti GD et al,14 Ramasamy P et al9 also have reported 54.3%, 49.4%, 63.3% and 56.0% of patients were admitted after 37 weeks of gestation.

In present study, caesarean section was performed in 47 (97.9%) patients and vaginal delivery occurred in 2.1% cases which present as minor degree of placenta previa. Studies by Brehan Y et al,20 Purohit A et al,13 Naik VR,8 Maiti GD et al14 and Ramasamy P et al9 have reported that caesarean section was performed in 92.9%, 92.5%, 81.1%, 93.3%, 100% respectively, majority of patients were delivered with caesarean section. So, it remains gold standard for management of placenta previa. Chances of recurrence of placenta previa are more common in major degree as compare to minor degree of placenta previa. Patients whose USG report shows low-lying placenta or placenta previa, repeat USG can be done at 36weeks and if it shows low-lying placenta lies between 1-2cm of internal os we can give trial of vaginal delivery. 10

In present study, majority of patients, 25(52.0%) had not any episode of bleeding. Out of these, 22 patients had major degree of placenta previa while 3 patients had minor degree of placenta previa. One or more episodes of bleeding occurred in 23 (45.8%). Single episode of bleeding occurred in 19 (39.6%) patients. Menon M.K.K et al21 and Lele S. B. et al15 had reported that, majority of patients had single episode of bleeding per vagina whereas in our study majority of patients had not experienced any episode of bleeding.

In our study, 22(45.8%) patients had developed PPH as there was excessive bleeding from sinuses. Medical management was done in form of uterotonics and pressure was applied for hemostasis in all patients. Complete hemostasis was achieved by medical management and / or surgical management. Bilateral uterine artery ligation (BLUAL) was performed in 19(39.6%). Obstetric hysterectomy was required in 4(8.3%) patients when all other modalities for management of PPH failed and in 2(4.2%) patients of adherent placenta(placenta accrete spectrum-PAS). On histopathological examination of specimens of these two obstetric hysterectomies, placenta accreta and placenta increta(PAS) were reported. In all patients of PPH, hypovolemia was corrected by crystalloid and blood transfusion. In present study, all 22(45.8%) patients required transfusion of blood and blood components. Naik VR et al,8 Yadava PA et al,22 Maiti GD et al14 have reported BLUAL in 26.3%, 52.3% and 13.3% respectively. Naik VR et al,8 Yadava PA et al,22 Maiti GD et al.14 have reported obstetric hysterectomy in 6.6%, 7.9%, 6.7% and blood transfusion in 36.8%, 36.4%, 36,7% respectively. Hence, BLUAL, obstetric hysterectomy and blood transfusion along with medical management are important modality of management in PPH of placenta previa.

Urinary bladder injury occurred in 2(4.2%) patients which was sutured. DIC, Renal failure occurred in 2(4.2%), and 1(2.1%) respectively. There were 2(4.2%) patients who had reported fever on day 3 of CS, which was managed medically and 1(2.1%) patient reported wound gap on day 14 of CS that was managed by re-suturing. Hence, in present study, major complications were bleeding episodes during antenatal period/APH in 23 (47.9%) and PPH in 22 (45.8%) patients. Maternal mortality occurred in 1 (2.1%) patient.

Naik VR et al,8 Yadava PA et al.,22 Maiti GD et al14 also have reported APH in 21.7%, 52.3%, 30.0% and PPH in 17.9%, 17.0%, 30.0% respectively as major complications of placenta previa. Naik VR et al.,8 Yadava PA et al,22 Maiti GD et al14 reported adherent placenta in 5.7%, 4.5%, 3.3% and maternal mortality in 0.9%, 2-3%, 0.0% respectively.

In present study, 32(66.7%) patients required blood transfusion in ante/intra/post-natal period. Hb level between 7– 8.9 g/dl, 9 – 10.9 g/dl and > 11 g/dl were reported in 5(10.4%), 20(41.7%) and 23(47.9%) patients respectively. Khosla et al.,23 had reported 95% of anemic patients who required blood transfusion while in present study, 21(43.7%) of anemic patients required blood transfusion. In present study, no patient was severely anaemic, majority of patients were registered who were taking regular antenatal care. Therefore, correction of anaemia by oral and/or injectable iron therapy and blood transfusion were advised as and when required.

In present study, 44(91.7%) babies were alive at the time of discharge. Ojha N. et al,19 Mathuriya G. et al.,11 Purohit A et al.,13 Berhan Y. et al.,20 Naik VR et al8 and Ramasamy P et al9 have reported 88.6%, 65.7%, 67.9%, 55.3%, 86.2% and 92.0% live births respectively. No IUD or Stillbirth occurred in present study. Purohit A et al.,13 and Naik VR et al,8 have reported 15.1% and 1.9% IUD.

In present study, neonatal mortality occurred in 4 (8.3%) due to preterm and prematurity followed by early onset septicemia and difficulty in maintaining saturation of preterm babies. Ojha N et al.,19 Mathuriya G. et al,11 Purohit A et al,13 Berhan Y. et al,20 Naik VR et al8 and Ramasamy P et al9 have reported neonatal mortality as 10.0%, 13.5%, 15.1%, 10.3%, 10.03% and 6.0% respectively. Out of 48 live births, 35(72.9%) babies did not require NICU admission and 13(27.1%) babies required NICU admission, out of these 4 died and 9 babies were discharged. In present study, majority of babies were alive due to higher number of registered patients who took regular antenatal care, hospital delivery and good NICU facilities.

Conclusion

No patient was severely anaemic as patients were aware of importance of antenatal care and haematinics. Majority of patients were delivered by CS. APH and PPH were major complications. About two third of patients required blood transfusion in ante/intra/post-natal period. Obstetric hysterectomy was required when other modalities of management of PPH failed or in adherent placenta in about one tenth of patients. Majority of babies were alive at the time of discharge due to higher number of registered patients who took regular antenatal care, hospital delivery and good NICU facilities.

Mainstay of management in patients of placenta previa is early diagnosis, careful evaluation, timely intervention by appropriate mode of delivery and management of complications. Feto-maternal morbidity and mortality can be reduced when placenta previa once diagnosed, should be managed at tertiary care hospital with availability of expert obstetrician, obstetric intensive care unit, sonologist, anaesthetist, well equipped neonatal intensive care units (NICU), and availability of blood and blood components. Patients and relatives must be made aware that, placenta previa is a high-risk pregnancy and therefore, there is a need for regular ANC, awareness about warning signs and delivery at a tertiary care hospital.

Prevention is better than cure. Multiparity increases the risk of placenta previa. Hence, family planning with an aim to reduce unwanted pregnancies and abortions will help to reduce the chances placenta previa. Caesarean section increases the risk of development of placenta previa. Efforts should be made to reduce the primary caesarean section rate as it poses more risk of placenta previa, morbidly adherent placenta and its related complications in subsequent gestations. Patient needs to be counselled regarding possibility of placenta previa when she demands delivery by caesarean section. In addition, patient who has history of previous caesarean section and history of D/E also needs to be counselled regarding possibility of placenta previa and complications associated with it. In present study, there were no any identifiable causes for placenta previa in primi gravida patients.

Source of Funding

None.

Conflict of Interest

None.

Acknowledgments

Authors would like thank superintendent and dean of our institution as well as patients and staff.

References

1 

Arulkumaran R Warren SS Arulkumaran Best practice in labour and delivery3rd EdCambridge University PressCambridge20091426

2 

Y Oylese JC Smulian Placenta previa, placenta accreta, and vasa previaObstet Gynecol2006107492741

3 

H Halen Key JR Scott RS Gibbs BT Karin AF Haney Placenta previa and AbruptionDanforth’s obstetrics and Gynecology9th edLippincott Williams & Wilkins200336571

4 

A Bahar A Abushan M Eskandar A Sobande M Alsunaidi Risk factors and pregnancy outcome in different types of placenta previaJ Obstet Gynaecol Can200931212631

5 

T Rosenberg G Pariente R Sergienko A Wiznitzer E Sheiner Critical analysis of risk factors and outcome of placenta previaArch Gynecol Obstet201028414751

6 

N Rahim R Taskin A Ara Risk factors associated with major placenta previaJ Med Sci2014222635

7 

N Meena A Dave S Meena A Meena A impact of placenta previa on obstetrics outcomeInt J Reprod Contracept Obste Gynec201547680

8 

VR Naik PM Cardoso A study of proportion, maternal and fetal outcomes in cases of placenta previaJ Dent Med Sci201817815

9 

P Ramasamy S Kumaresan S Manoharan A clinical study on maternal and fetal outcome in scarred and unscarred uterus of placenta previa20211021479

10 

Williams Obstetrics25th EdMcgraw Hill Medical PublicationNew York201877395

11 

G Mathuriya P Lokhande Comparative study of obstetrics outcome between scarred and unscarred uterus in placenta previa casesIndian J Clin Pract20213271922

12 

N Banu N Begum Caesarean delivery increases delivery increases subsequent risk of placenta previaBangladesh J Physiol Pharmacol2009251&2137

13 

A Purohit R Desai B Jodha B Garg Maternal and Fetal outcome in Third Trimesters BleedingIOSR J Dent Med Sci2014135136

14 

GD Maiti M Adhikary PR Lele S Gupta M Saha S Maiti Maternal and fetal outcome in placenta previa: our experienceInt J Reprod Contracept Obstet Gynecol2020932539

15 

SB Lele JT Punjabi ND Motashaw BN Purandare A review of 340 cases of placenta previaAm J Obstel Gynaecol India19681163641

16 

B Das Antepartum haemorrhage in three decadesJ Obstet Gynaecol India19752563641

17 

L Tuzovic J Djelmis M Ilijec Obstetric risk factors associated with placenta previa development: case-control studyCroat Med J200344672833

18 

K Jillani F Shaikh S Siddiqui M Siddiqui Repeated cesarean sections: A risk factor for rising rate of placenta previa. Gynaecol Obstet. 2010;16(3):409-12.Gynaecol Obstet20106340912

19 

N Ojha Obstetric factors and pregnancy outcome in placenta previaJ Inst Med Nepal20123423841

20 

Y Berhan Predictors of perinatal mortality associated with placenta previa and placental abruption: an experience from a low income countryJ Pregnancy2014201430704310.1155/2014/307043

21 

MKK Menon An evaluation of management of placenta previa, 1929-1961; A 3 year surveyJ Obstet Gynaecol Br Commonw1963708787

22 

PA Yadava RR Patel AS Mehta AS Mehta Placenta previa: risk factors, feto-maternal outcome and complicationsInt J Reprod201981248426

23 

A Khosla V Dahiya K Sangwan S Rathee Perinatal outcome in antepartum haemorrhageJ Obstet Gyn India19899714



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

287-293


Authors Details

Gautam Chandubhai Gavaniya, Rajal Vidyutkumar Thaker, Meera Hasmukhbhai Radadiya, Pallavi Ishawarbhai Patel*, Shivam Jagdishbhai Barot, Karan Kantibhai Desai


Article History

Received : 04-12-2023

Accepted : 20-03-2024


Article Metrics


View Article As

 


Downlaod Files